Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Long-Term Investments: 2020-2021

  • GeneDx Holdings' Long-Term Investments was N/A to $442.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $442.8 million, marking a year-over-year change of. This contributed to the annual value of $442.8 million for FY2020, which is N/A change from last year.
  • GeneDx Holdings' Long-Term Investments amounted to $442.8 million in Q2 2021, which was up 0.00% from $442.8 million recorded in Q1 2021.
  • GeneDx Holdings' 5-year Long-Term Investments high stood at $442.8 million for Q2 2021, and its period low was $442.8 million during Q3 2020.
  • In the last 2 years, GeneDx Holdings' Long-Term Investments had a median value of $442.8 million in 2020 and averaged $442.8 million.